Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cutera | CUTR | Aug 30, 2024 | 0.76 | -3.93 |
CVB Financial | CVBF | Aug 30, 2024 | 18.42 | +0.38 |
CVD Equipment | CVV | Aug 30, 2024 | 3.80 | -1.52 |
CVR Energy | CVI | Aug 30, 2024 | 25.42 | +3.00 |
Cvr Partners LP Unit | UAN | Aug 30, 2024 | 70.24 | +1.23 |
CVRx | CVRX | Aug 30, 2024 | 9.86 | 0.00 |
CVS Health | CVS | Aug 30, 2024 | 57.24 | +0.47 |
CXApp A | CXAI | Aug 30, 2024 | 2.09 | -0.95 |
CyberArk Software | CYBR | Aug 30, 2024 | 286.74 | +0.08 |
Cybin | CYBN | Aug 30, 2024 | 0.26 | -0.47 |
Cyclacel Pharmaceuticals | CYCC | Aug 30, 2024 | 1.05 | +1.15 |
Cyclacel Pharmaceuticals Pref | CYCCP | Aug 30, 2024 | 8.01 | -9.70 |
Cyclerion Therapeutics | CYCN | Aug 30, 2024 | 2.93 | -6.98 |
Cyclo Therapeutics | CYTH | Aug 30, 2024 | 0.75 | -2.88 |
Cyngn | CYN | Aug 30, 2024 | 3.70 | -3.65 |
Cytek Biosciences | CTKB | Aug 30, 2024 | 5.74 | +0.88 |
Cytokinetics | CYTK | Aug 30, 2024 | 57.08 | -0.54 |
Cytomed Therapeutics | GDTC | Aug 30, 2024 | 1.48 | +2.16 |
CytomX Therapeutics | CTMX | Aug 30, 2024 | 1.18 | +2.61 |
Cytosorbents | CTSO | Aug 30, 2024 | 1.05 | +2.94 |
D-MARKET Electronic Services & Trading ADR | HEPS | Aug 30, 2024 | 2.73 | +1.11 |
D-Wave Quantum | QBTS | Aug 30, 2024 | 1.01 | +1.00 |
D.R. Horton | DHI | Aug 30, 2024 | 188.76 | +1.02 |
Dada Nexus ADR | DADA | Aug 30, 2024 | 1.09 | -1.80 |
Daily Journal | DJCO | Aug 30, 2024 | 497.11 | +1.14 |
Dakota Gold | DC | Aug 30, 2024 | 2.32 | -3.33 |
Daktronics | DAKT | Aug 30, 2024 | 14.45 | -1.10 |
DallasNews A | DALN | Aug 30, 2024 | 4.15 | -2.81 |
Dana | DAN | Aug 30, 2024 | 11.29 | +1.07 |
Danaher | DHR | Aug 30, 2024 | 269.31 | +0.86 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.